Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Siemens AG    SIE   DE0007236101

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Siemens AG : WSJ BLOG/Health : Siemens Sees Resurgence in Diagnostics as a Cost Cutter

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/13/2012 | 07:02pm CET

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Shirley S. Wang

The Health Blog caught up at TEDMED with Gregory Sorensen, chief executive of Siemens Healthcare in North America, to talk about the changing health-care field and what it means for diagnostics, an area in which Siemens is a player.

"We're beginning to see resurgence in diagnostics as a way to save costs, " Sorensen, formerly a radiology professor at Harvard Medical School, told the Health Blog.

A missed diagnosis is a big cost driver in health care because it wastes time and money on ineffective therapy, he said, pointing to an example of studies in Alzheimer's showing that upon autopsy, some 15%-20% of patients examined had a different ailment than believed and would have been treated differently when they were alive.

Of course, there's been an outcry about the unnecessary use of medical tests and Sorensen acknowledges there has been overuse in the past. Reductions in Medicare reimbursement rates have curbed overuse, he says, though not everyone agrees on that, as the Health Blog reported last week. The important thing now, Sorensen says, is to make sure people are getting the right diagnostic tests, rather than reduce the absolute number of them.

He recalled being a doctor in training in the late 1980s, when his professors taught him that, because of the risks associated with appendicitis, doctors should be conservative whenever a patient reported pain in the lower right quadrant of the abdomen. A good surgeon, therefore, would do exploratory surgery on five patients for every one that actually had appendicitis. Sorensen himself had his appendix -- which turned out to be healthy -- removed during this era.

Now patients get scanned if they report such pain, resulting in many fewer unnecessary surgeries, said Sorensen.

Siemens recognizes how important it is to demonstrate effectiveness in today's health-care business, and that payers want to see results, says Sorensen. As for the shift to reimbursement for value, "that train has left the station."

 
 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SIEMENS AG
02/16 Siemens to separate Mechanical Drives business
02/16 SIEMENS : to secure long-term competitiveness of mechanical drives unit
02/15 SIEMENS : to shut Danish wind blade factory, lay off 430 people
02/10 SIEMENS : considers U.S. listing of healthcare arm - CEO in Euro am Sonntag
02/09 SIEMENS : at the Hannover Messe 2017
02/07 SIEMENS : Nearly every second employee also a shareholder
02/06 EU regulators to decide on Siemens, Gamesa deal by March 13
02/06 SIEMENS : aiming for early EU approval for Gamesa deal - sources
02/02DJSIEMENS : CEO Frets About America -- WSJ
02/02 SIEMENS : ex-dividend day for annual dividend
More news
Sector news : Industrial Conglomerates
06:38pDJDOW CHEMICAL : DuPont on Track for Merger Approval From EU Regulators -- Update
05:58p EU regulators set to clear Dow, DuPont deal - sources
05:58pDJDOW CHEMICAL : DuPont on Track to Win Merger Clearance From EU Regulators -- Sou..
02/21 Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
02/17 S&P downgrade warning sends Toshiba shares falling
More sector news : Industrial Conglomerates
News from SeekingAlpha
02/15 Siemens to shut Danish wind blade factory
02/14 Dassault Systemes Priced Like The Leader It Is
02/14 Wave Power - Is It Going To Work?
02/10 Trump Deals With China; Who Wins?
02/10 Industrial Software And The Future Of General Electric
Advertisement
Financials (€)
Sales 2017 83 766 M
EBIT 2017 9 014 M
Net income 2017 6 264 M
Debt 2017 17 509 M
Yield 2017 3,05%
P/E ratio 2017 16,10
P/E ratio 2018 15,31
EV / Sales 2017 1,48x
EV / Sales 2018 1,38x
Capitalization 106 250 M
More Financials
Chart SIEMENS AG
Duration : Period :
Siemens AG Technical Analysis Chart | SIE | DE0007236101 | 4-Traders
Full-screen chart
Technical analysis trends SIEMENS AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 127 €
Spread / Average Target 1,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Josef Kaeser President & Chief Executive Officer
Gerhard Cromme Chairman-Supervisory Board
Ralf Peter Thomas Chief Financial Officer
Helmuth Ludwig Chief Information Officer
Michael Diekmann Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SIEMENS AG7.02%111 839
GENERAL ELECTRIC COMPA..-3.42%269 992
3M CO2.69%109 325
HONEYWELL INTERNATIONA..7.65%94 929
E I DU PONT DE NEMOURS..5.15%66 728
JARDINE MATHESON HOLDI..12.76%45 288
More Results